September 22, 2022
U.S. Embarks on Latest COVID-19 Vaccination Campaign as New Bivalent Boosters Roll Out
“With a jumble of confusion, eagerness and vaccine fatigue, America embarked in earnest last week on a sprawling new campaign to get Omicron-specific boosters into the arms of a pandemic-weary country.” Millions of doses of bivalent boosters “arrived with little ceremony at pharmacies, nursing homes and clinics across the country, ready to be administered in what health officials now expect to become a yearly inoculation ritual akin to a flu shot.” Early data “from states and several cities showed what health officials described as a robust early response in a moment when vaccine rates have stagnated.”
The New York Times 9/18
COVID-19 Linked to Increased Alzheimer’s Risk
COVID-19 has been linked to a significantly increased risk for new-onset Alzheimer’s disease (AD) a new study suggests.
The study of more than 6 million people aged 65 years or older found a 50% – 80% risk for AD in the year after COVID-19. The risk was especially high for women older than 85 years.
However, the investigators were quick to point out that the observational retrospective study offers no evidence that COVID-19 causes AD. There could be a viral etiology at play, or the connection could be related to inflammation in neural tissue from the SARS-CoV-2 infection. Or it could simply be that exposure to the healthcare system for COVID increased the odds of detection of existing undiagnosed AD.
Journal of Alzheimer’s Disease 9/13
September 15, 2022
NY State of Emergency on Polio Outbreak
New York Governor Kathy Hochul declared a state of emergency on Friday over the growing polio outbreak, in an effort to better equip health care providers with tools to curb the spread of the sometimes disabling virus before it takes further hold in the state.
New York Times – 9/9/22 Sept. 9
Skin Test to Detect Alzheimer’s
A report given at the Alzheimer’s Association Inter-national Conference suggests that a minimally invasive skin test can accurately diagnose Alzheimer’s Disease with accuracy. The test measures factors related to nerve connections in the brain. The chief medical advisor for SYNAPS the company that developed the test stated that when added to other diagnostic methods “tremendously enhance the certainty of making a diagnosis,” of Alzheimer’s Disease.
September 8, 2022
The CDC reminds us that, a Newsroutine annual influenza vaccination is recommended for all persons aged 6 months and older who do not have contraindications. For each recipient, a licensed and age-appropriate vaccine should be used. With the exception of vaccination for adults aged 65 years and older, Advisory Committee on Immunization Practices (ACIP) makes no preferential recommendation for a specific vaccine when more than one licensed, recommended, and age-appropriate vaccine is available. All seasonal influenza vaccines expected to be available in the United States for the 2022–23 season are quadrivalent, that is contain vaccine for four different strains of flu. COVID and flu vaccines can be delivered concurrently
—Morbidity and Mortality Weekly Report of the CDC